Acne Medication Market Size By Formulation (Topical, Oral), By Product (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid), By Type (Prescription, OTC), By Age Group (0-10 years, 11-16 years, 17-25 years, 26-40 years, 41-60 years, 61-80 years, 80+ years), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Nov 2018  |  Report ID: GMI3010  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 200   |   Base Year: 2017

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Acne Medication Market size was valued over USD 4.5 billion in 2017 and is expected to witness more than 6.5% CAGR from 2018 to 2024.  

Acne Medication Market

Get more details on this report - Request Free Sample PDF

Increasing prevalence and severity of acne globally will drive the global market over the projection years. Acne vulgaris is the most common skin problem amongst the teenaged population, with women being affected at higher rates than men. According to the Global Burden of Disease study, acne vulgaris affects approximately 85% of young adults aged between 12–25 years.

Various factors such as fluctuating hormone levels, unhygienic lifestyle and excessive production of oil from sebaceous glands have increased the prevalence of acne, thereby positively affecting the market growth. In addition, western countries are more prone to acne due to the population’s dietary regimen characterized by high amounts of sugar, refined grains, high protein, and high-fat dairy products, hence boosting the market growth in countries such as U.S., UK and France. 

Acne Medication Market, By Formulation

China acne medication market By formulation

Get more details on this report - Request Free Sample PDF

Topical acne medication industry segment held significant share of total product market valuation, accounting for a total value of USD 2,914.3 million 2017. Topical medication includes gel, creams and ointments that contain retinoids, salicylic acid, benzoyl peroxide and others. Factors such as lesser cost, lower risk of systemic adverse events and drug interactions will drive the market segment growth.

Oral acne medication indutry segment is estimated to expand at a CAGR of 6.9% over the forecast period. Such medications are quite effective where moderate to severe acne do not respond to topical agents. Oral medications such as antibiotics, birth control pills, isotretinoin get absorbed throughout one’s entire body, hence driving the segment growth in the near future.

Acne Medication Market, By Product

Retinoids market segment dominated the industry, accounting for USD 1,299.9 million in 2017. Retinoids (such as Retin-A and Differin) are the most effective for moderate to severe acne as unclogs pores, allowing other topical creams and gels to work better, thus driving the market growth. In addition, retinoids decrease post-inflammatory hyperpigmentation, while simultaneously preventing the formation of any new acne on the skin, hence increasing its application in the market.

Azelaic acid market segment is estimated to expand at a CAGR of 7.6% during the forecast timeframe. Azelaic acid is extremely gentle on skin as compared to retinoids and benzoyl peroxide and can be easily used on super sensitive skins, thereby increasing its growth rate in the forecast period. Furthermore, azelaic acid is a good acne treatment choice for pregnant and nursing moms unlike other topical retinoids and oral acne medications, hence driving the segment growth.

Acne Medication Market, By Type

Over-the-counter (OTC) segment generated maximum revenue share in the year 2017 with a value of USD 2,420.9 million. Increased preference of patient population to use OTC products as they are convenient to purchase and inexpensive is propelling the market growth.

Prescription acne medication market segment is expected to experience robust growth of 6.3% over the projection period. Prescription acne products such as antibiotics are usually combined with benzoyl peroxide or a topical retinoid, that makes up for an effective combination, hence driving the prescription acne medication industry growth.

Acne Medication Market, By Age Group

10-16 years age group market segment generated maximum revenue share in the year 2017 with a value of USD 1,772.1 million. Factors such as hormonal changes that come with puberty, hereditary aspects, and sedentary lifestyles that are very common in 10-16 years of age category is driving the market growth. According to the American Academy of Dermatology, almost 100% of all teenagers go through occasional acne breakouts.

17-25 years age group market segment is expected to experience robust growth at 6.7% over the projection period. Increasing incidence of sedentary habits such smoking, drinking and consumption of fatty foods will drive the growth of acne medication market in 17-25 years age group.

Acne Medication Market, By Region

Europe acne medication market by country

Get more details on this report - Request Free Sample PDF

U.S. market valued USD 2,331.5 million in the year 2017. Acne is the most common skin condition in the U.S., affecting up to 50-60 million Americans annually. Presence of better acne treatment options, increased affordability and greater awareness regarding acne treatment is boosting the market in the U.S.

India market is estimated to expand at a CAGR of 9.2% during the forecast timeframe. India has an estimated 200–300 million acne sufferers, that will eventually aid the market growth in India. Furthermore, increasing demand of the population to spend on facial appearance is also boosting the market growth in India.

Competitive Market Share

Some of the leading key players include Johnson & Johnson, Allergan plc, Galderma S.A., Reckitt Benckiser Group, Guthy-Renker, Stiefel Laboratories, Valeant Pharmaceuticals, Bayer AG, BioPharmX, and others. These companies have implemented strategic decisions such as partnerships and mergers to expand their product portfolio and geographic reach. In September 2018, Almirall SA finalized USD 550 million acquisition of four approved products and one new drug candidate from Allergan's medical dermatology unit in the U.S. Such acquisitions will aid in the expansion of product portfolio in acne medication industry.  

Acne Medication Industry Background

Acne medication industry is fragmented with number of players capturing major share in the global market. The market is expected to grow moderately due to the intense market clutter to find the best acne treatment options. Growing number of acne problems in developed as well as developing regions is positively influencing the market growth. North America has captured majority market share as severe acne prevalence is very common in the region, affection millions of people each year.

Frequently Asked Questions (FAQ) :

The market size of acne medication crossed USD 4.5 billion in 2017.
The industry share of acne medication is expected to witness more than 6.5% CAGR from 2018 to 2024.
As per Global Market Insights, Inc. the worldwide market will register a CAGR of 6.5% over 2018-2024.
According to the study, oral acne medication will witness a CAGR of 6.9% over 2018-2024. The approach is widely used where the acne doesn’t respond to the topical agents.
The segment registered a revenue share of USD 2,420.9 million in 2017 and is expected to witness massive gains over the years owing to the affordability and easy accessibility of these medications.

Premium Report Details

  • Published Date: Nov 2018
  • Pages: 200
  • Tables: 233
  • Charts / Figures: 10
  • Companies covered: 13
  • Countries covered: 17

Get a report that explains COVID-19 impact on this market, request a free sample now

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X